Baader Bank Analysts Give Brenntag (BNR) a €50.00 Price Target
Brenntag (FRA:BNR) has been assigned a €50.00 ($58.14) target price by analysts at Baader Bank in a research note issued on Friday. The brokerage currently has a “buy” rating on the stock. Baader Bank’s price objective would suggest a potential upside of 20.63% from the company’s previous close.
A number of other analysts have also weighed in on the stock. BNP Paribas set a €64.00 ($74.42) price objective on shares of Brenntag and gave the stock a “buy” rating in a research note on Tuesday, October 2nd. Deutsche Bank set a €48.00 ($55.81) price target on shares of Brenntag and gave the company a “buy” rating in a research report on Friday, November 23rd. Nord/LB set a €43.00 ($50.00) price target on shares of Brenntag and gave the company a “neutral” rating in a research report on Thursday, November 22nd. Jefferies Financial Group set a €42.00 ($48.84) price objective on shares of Brenntag and gave the company a “neutral” rating in a report on Friday, December 21st. Finally, UBS Group set a €60.00 ($69.77) price objective on shares of Brenntag and gave the company a “buy” rating in a report on Tuesday, October 9th. Six research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Brenntag presently has a consensus rating of “Buy” and an average target price of €52.79 ($61.38).
Shares of Brenntag stock opened at €41.45 ($48.20) on Friday. Brenntag has a 12-month low of €43.06 ($50.07) and a 12-month high of €56.25 ($65.41).
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.